Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hong Kong Fushi Bioengineering Co., Limited was a Hong Kong-based company primarily engaged in the production and marketing of dietary supplements and traditional herbal products. The company was best known for its male enhancement and weight loss supplements, which were distributed internationally under various brand names. However, the firm frequently appeared in public health advisories from agencies such as the U.S. Food and Drug Administration (FDA) due to the presence of undeclared synthetic pharmaceutical ingredients in its products. These products were often marketed as natural alternatives but contained substances like sildenafil or sibutramine. The company was officially incorporated in 2004 and dissolved in 2015. Its business model focused on commercial-scale distribution rather than proprietary drug discovery or clinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hong Kong Fushi Bioengineering.